Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christina Dold

Showing results (11-20 of 70) with videos related to

Pageof 7
Sort By:
Clinical and Vaccine Immunology : CVI|November 17, 2016
Serum Bactericidal Antibody Responses of Adults Immunized with the MenB-4C Vaccine against Genetically Diverse Serogroup B MeningococciSerena Giuntini, Eduardo Lujan, Malick M Gibani, et al.
Vaccine|August 14, 2024
Immunogenicity of a 30-valent M protein mRNA group A Streptococcus vaccineMeredith B Finn, Thomas A Penfound, Sanaz Salehi, et al.
Msphere|July 5, 2019
Anti-Factor H Antibody Reactivity in Young Adults Vaccinated with a Meningococcal Serogroup B Vaccine Containing Factor H Binding ProteinKelsey Sharkey, Peter T Beernink, Joanne M Langley, et al.
Plos One|October 15, 2015
FetA Antibodies Induced by an Outer Membrane Vesicle Vaccine Derived from a Serogroup B Meningococcal Isolate with Constitutive FetA ExpressionHolly Sanders, Gunnstein Norheim, Hannah Chan, et al.
Vaccine|May 24, 2022
Application of a Neisseria meningitidis antigen microarray to identify candidate vaccine proteins from a human Phase I clinical trialChun-Mien Chang, Amaka M Awanye, Leanne Marsay, et al.
Vaccine|April 10, 2023
Immunisation with purified Coxiella burnetii phase I lipopolysaccharide confers partial protection in mice independently of co-administered adenovirus vectored vaccinesChristina Dold, Henderson Zhu, Laura Silva-Reyes, et al.
Plos One|February 13, 2016
Impact of Reducing Complement Inhibitor Binding on the Immunogenicity of Native Neisseria meningitidis Outer Membrane VesiclesHelene Daniels-Treffandier, Karlijn de Nie, Leanne Marsay, et al.
Msphere|January 26, 2022
Human B Cell Responses to Dominant and Subdominant Antigens Induced by a Meningococcal Outer Membrane Vesicle Vaccine in a Phase I TrialChristine S Rollier, Christina Dold, Leanne Marsay, et al.
Science Translational Medicine|June 21, 2023
An adenoviral-vectored vaccine confers seroprotection against capsular group B meningococcal diseaseChristina Dold, Leanne Marsay, Nelson Wang, et al.
NPJ Vaccines|June 8, 2026
Pre-clinical efficacy of a candidate outer membrane vesicle gonococcal vaccine in comparison with 4CMenBPaula Freixeiro, Lisa A Lewis, Leonor Sánchez-Busó, et al.
Pageof 7

Showing results (11-20 of 70) with videos related to

Sort By:
Pageof 7
Clinical and Vaccine Immunology : CVI|November 17, 2016
Serum Bactericidal Antibody Responses of Adults Immunized with the MenB-4C Vaccine against Genetically Diverse Serogroup B MeningococciSerena Giuntini, Eduardo Lujan, Malick M Gibani, et al.
Vaccine|August 14, 2024
Immunogenicity of a 30-valent M protein mRNA group A Streptococcus vaccineMeredith B Finn, Thomas A Penfound, Sanaz Salehi, et al.
Msphere|July 5, 2019
Anti-Factor H Antibody Reactivity in Young Adults Vaccinated with a Meningococcal Serogroup B Vaccine Containing Factor H Binding ProteinKelsey Sharkey, Peter T Beernink, Joanne M Langley, et al.
Plos One|October 15, 2015
FetA Antibodies Induced by an Outer Membrane Vesicle Vaccine Derived from a Serogroup B Meningococcal Isolate with Constitutive FetA ExpressionHolly Sanders, Gunnstein Norheim, Hannah Chan, et al.
Vaccine|May 24, 2022
Application of a Neisseria meningitidis antigen microarray to identify candidate vaccine proteins from a human Phase I clinical trialChun-Mien Chang, Amaka M Awanye, Leanne Marsay, et al.
Vaccine|April 10, 2023
Immunisation with purified Coxiella burnetii phase I lipopolysaccharide confers partial protection in mice independently of co-administered adenovirus vectored vaccinesChristina Dold, Henderson Zhu, Laura Silva-Reyes, et al.
Plos One|February 13, 2016
Impact of Reducing Complement Inhibitor Binding on the Immunogenicity of Native Neisseria meningitidis Outer Membrane VesiclesHelene Daniels-Treffandier, Karlijn de Nie, Leanne Marsay, et al.
Msphere|January 26, 2022
Human B Cell Responses to Dominant and Subdominant Antigens Induced by a Meningococcal Outer Membrane Vesicle Vaccine in a Phase I TrialChristine S Rollier, Christina Dold, Leanne Marsay, et al.
Science Translational Medicine|June 21, 2023
An adenoviral-vectored vaccine confers seroprotection against capsular group B meningococcal diseaseChristina Dold, Leanne Marsay, Nelson Wang, et al.
NPJ Vaccines|June 8, 2026
Pre-clinical efficacy of a candidate outer membrane vesicle gonococcal vaccine in comparison with 4CMenBPaula Freixeiro, Lisa A Lewis, Leonor Sánchez-Busó, et al.
Pageof 7